This is a comparative study to evaluate response rate to mitoguazone (MGBG) and vinblastine (VLB) in 52 evaluable patients with advanced transitional cell carcinoma of the urinary tract. Of 38 patients with measurable disease, two of 18 (11%) on MGBG had partial remission (95% confidence interval: 0.01, 0.35), whereas four of 20 (20%) responded on the VLB arm (95% confidence level: 0.06-0.44). Both responses on the MGBG arm were seen in patients given prior chemotherapy. Side effects of both drugs were significant, with 46% of patients given VLB developing severe or life-threatening hematologic toxicity. Data indicate that both drugs, as single agents, are probably inferior to cisplatin for control of advanced transitional cell carcinoma of the urinary tract.

Download full-text PDF

Source
http://dx.doi.org/10.1002/1097-0142(19891215)64:12<2445::aid-cncr2820641208>3.0.co;2-jDOI Listing

Publication Analysis

Top Keywords

advanced transitional
12
transitional cell
12
cell carcinoma
12
carcinoma urinary
12
urinary tract
12
95% confidence
8
phase study
4
study mitoguazone
4
mitoguazone vinblastine
4
vinblastine advanced
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!